E2s |
|
|
|
|
|
UBE2T |
FANCT, HSPC150 |
E2 |
1q32.1 |
Fanconi anemia, complementation group T; pancytopenia [3] |
UBE2T is an E2 that ubiquitinates FANCL and FANCD2; mutation leads to genome instability and bone marrow failure [3] |
E3s |
|
|
|
|
|
BIRC4 |
XIAP |
RING E3 Ub ligase |
Xq25 |
Lymphoproliferative syndrome, X-linked [4] |
Restricts apoptosis through interactions with various caspases; mutation leads to increased susceptibility to apoptotic stimuli [4] |
CBL |
C-CBL, RNF55 |
RING E3 Ub ligase |
11q23.3 |
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia [5] |
Ubiquitinates multiple receptor protein-tyrosine kinases; mutations lead to hyper-responsiveness to multiple cytokines and increased proliferation [5] |
FANCL |
POG |
RING E3 Ub ligase |
2p16.1 |
Fanconi anemia, complementation group L; pancytopenia [6] |
FANCL monoubiquitinates FANCD2 in response to DNA damage; mutation leads to genome instability and bone marrow failure [6] |
MIB1 |
DIP-1 |
RING E3 Ub ligase |
18q11.2 |
Left-ventricular noncompaction 7 [7] |
Reduced NOTCH 1 activity in peripheral blood leading to potential B and T cell defects [7,8] |
RBCK1 |
HOIL-1, HOIL-1L |
RBR E3 Ub ligase |
20p13 |
Polyglucosan body myopathy 1 with or without immunodeficiency [9] |
Defects in LUBAC lead to NFKB dysregulation, leading to both immunodeficiency and autoinflammation [9] |
RNF31 |
HOIP |
RBR E3 Ub ligase |
14q12 |
Multiorgan autoinflammation, combined immunodeficiency, subclinical amylopectinosis, and systemic lymphanqiectasia [10] |
Phenolype overlaps with HOIL1/RBCK1 mutated patients [10] |
RAG1 |
RNF74 |
RING E3 Ub ligase |
11 p12 |
Severe combined immunodeficiency, Omenn syndrome [11,12] |
RAG1 is required for assembling mature antigen receptors on B & T lymphocytes; mutations in the RING domain impairs ubiquitin ligase activity and recombination [11,12] |
RNF125 |
TRAC1 |
RING E3 Ub ligase |
18q12.1 |
Tenorio syndrome [13] |
Defects in RIG-I-IPS1-MDA5, interferon, PI3K-Akt signaling leading to a Sjögren-like syndrome [13] |
RNF168 |
|
RING E3 Ub ligase |
3q29 |
RIDDLE syndrome; immunodeficiency [14] |
RNF168 is an E3 ubiquitin ligase critical for DNA double-strand break repair; mutations lead to defective DNA repair and immunodeficiency [14] |
SLX4 |
BTB12 |
BTB/POZ domain; SUMO E3 ligase |
16p13.3 |
Fanconi anemia, complementation group P; pancytopenia [15,16] |
SLX4 interacts with SUMO-charged E2 UBC9 and functions as a SUMO E3 ligase; important for the local replicative DNA repair response [15,16] |
TRAF3 |
LAP1, CAP1 |
RING E3 Ub ligase |
14q32.32 |
Possible association with susceptibility to Herpes simplex vims (HSV) encephalitis [17] |
Dominant-negative mutant TRAF3 impairs responsiveness to TLR3 agonists such as HSV [17] |
ITCH |
AIF4, AIP4, NAPP1 |
HECT E3 Ub ligase |
20q 11.22 |
Autoimmune disease, multisystem, with facial dysmorphism [18] |
Cooperates with A20 and CYLD to terminate NFKB signaling; implicated in multiple signaling pathways, mutations lead to immune dysrequlation [18, 19] |
DUBS |
|
|
|
|
|
TNFAIP3 |
A20 |
ZnF E3 Ub ligase; OTU domain, DUB |
6q23_3 |
Autoinflammatory syndrome, familial, Behcet-like [20] |
Mutations leading to truncated A20 increased NFKB activity due to defective removal of K634inked ubiquitin from RIPK1, NEMO, and TRAF6 [20] |
OTULIN |
AIPDS, FAM105B |
OTU domain, DUB |
5p15.2 |
Autoinflammation, panniculitis, and dermatosis syndrome [21] |
OTULIN-deflcient patients have increased linear ubiquitination of ASC, NEMO, RIPK1. TNFR1, leading to severe inflammation [21] |